Multisite phosphorylation and the integration of stress signals at p53

被引:183
作者
Meek, DW [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
关键词
p53; phosphorylation; signal integration; stress; DNA damage;
D O I
10.1016/S0898-6568(97)00119-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The p53 tumour suppressor protein is a potent transcription factor that plays a major role in the defence against tumour development. p53 exists in a latent form that can be activated by a range of stresses in eluding DNA damage, hypoxia, cytokines, metabolic changes, viral infection, and activated oncogenes. Activation of p53 can lead to cellular growth arrest prior to entry into either S phase or mitosis or can trigger cell death through apoptosis. The modification of p53 by multisite phosphorylation provides a potential link between stress signalling and the regulation of p53 activity, and there is now striking evidence that agents that activate p53 can lead to selective changes in its phosphorylation status. Topologically, the phosphorylation sites in p53 fall into two discrete functional domains. Four phosphorylation events take place within the N-terminal 83 amino acids containing the transactivation domain and a region involved in transcription-independent growth suppression. At least three of these modifications occur in response to agents that cause cellular stress such as DNA damage. At the C-terminus, there are three phosphorylation events, each of which can independently regulate the specific DNA-binding function of p53, suggesting convergent control by different signalling pathways. The multiplicity of these covalent modifications and their responsiveness to a wide range of signals suggest that p53 activity is tightly and coordinately controlled in response to stresses and changes in the cellular environment. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 111 条
[41]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582
[42]   ACTIVATION OF THE CRYPTIC DNA-BINDING FUNCTION OF MUTANT FORMS OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
NUCLEIC ACIDS RESEARCH, 1993, 21 (14) :3167-3174
[43]   2 DISTINCT SIGNALING PATHWAYS ACTIVATE THE LATENT DNA-BINDING FUNCTION OF P53 IN A CASEIN KINASE-II-INDEPENDENT MANNER [J].
HUPP, TR ;
LANE, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :18165-18174
[44]   REGULATION OF THE CRYPTIC SEQUENCE-SPECIFIC DNA-BINDING FUNCTION OF P53 BY PROTEIN-KINASES [J].
HUPP, TR ;
LANE, DP .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :195-206
[45]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886
[46]   Cell-cycle control and its watchman [J].
Jacks, T ;
Weinberg, RA .
NATURE, 1996, 381 (6584) :643-644
[47]   The recognition of DNA damage [J].
Jackson, SP .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :19-25
[48]   DNA DOUBLE-STRAND BREAK REPAIR AND V(D)J RECOMBINATION - INVOLVEMENT OF DNA-PK [J].
JACKSON, SP ;
JEGGO, PA .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (10) :412-415
[49]   ACTIVATION OF P53 SEQUENCE-SPECIFIC DNA-BINDING BY SHORT SINGLE STRANDS OF DNA REQUIRES THE P53 C-TERMINUS [J].
JAYARAMAN, L ;
PRIVES, C .
CELL, 1995, 81 (07) :1021-1029
[50]  
Jongmans W, 1996, ONCOGENE, V13, P1133